Antitrypanosomal activities of proteasome inhibitors

Seven peptidyl proteasome inhibitors were tested for in vitro activity against Trypanosoma brucei bloodstream forms. Two compounds showed activity in the low nanomolar range. In general, trypanosomes were more susceptible to the compounds than were human HL-60 cells. The data support the potential o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nkemngu, Njinkeng (VerfasserIn) , Rosenkranz, Vera (VerfasserIn) , Wink, Michael (VerfasserIn) , Steverding, Dietmar (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2002
In: Antimicrobial agents and chemotherapy
Year: 2002, Jahrgang: 46, Heft: 6, Pages: 2038-2040
ISSN:1098-6596
DOI:10.1128/AAC.46.6.2038-2040.2002
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1128/AAC.46.6.2038-2040.2002
Volltext
Verfasserangaben:Joseph Nkemgu-Njinkeng, Vera Rosenkranz, Michael Wink and Dietmar Steverding
Beschreibung
Zusammenfassung:Seven peptidyl proteasome inhibitors were tested for in vitro activity against Trypanosoma brucei bloodstream forms. Two compounds showed activity in the low nanomolar range. In general, trypanosomes were more susceptible to the compounds than were human HL-60 cells. The data support the potential of proteasome inhibitors for rational antitrypanosomal drug development.
Beschreibung:Gesehen am 05.10.2017
Beschreibung:Online Resource
ISSN:1098-6596
DOI:10.1128/AAC.46.6.2038-2040.2002